A3BC Steering Committee Membership:

  • Lyn March (University of Sydney, NSW)
  • Chris Jackson  (University of Sydney, NSW)
  • Meilang Xue  (University of Sydney, NSW)
  • Marissa Lassere (University of NSW, NSW)
  • Jane Munro (Murdoch Children’s Research Institute, VIC)
  • Catherine Hill (Queen Elizabeth Hospital, SA)
  • Mihir Wechalekar (Flinders Medical Centre, SA)
  • Susan Lester (Basil Hetzel Institute, SA)
  • Ranjeny Thomas (University of Queensland, QLD)
  • Helen Benham, (University Queensland, QLD)
  • Tony Kenna (Queensland University of Technology, QLD)
  • Helen Keen (Fiona Stanley Hospital, WA)
  • Chandima Perera (Canberra Hospital, ACT)
  • National Director: Craig Willers (NSW)

Key governance information:

  • The overarching A3BC governance philosophy is one of collaboration and cooperation to emphasize capacity building and career development for the future
  • The A3BC is owned and operated as an unincorporated joint venture between a consortium of lead biobank and data custodians. The A3BC Consortium Committee will provide quality oversight and developmental guidance for the A3BC, to be executed through the National Biobank Director. The Consortium Committee will be charged with implementing best practice processes and procedures across the national operation.
  • Decision-making by the Consortium Committee will be guided by ethical, legal and social implications advice to be provided by the ELSI Advisory Group. An important task for the ELSI Advisory Group will be to incorporate ethical, legal and public concerns into A3BC development and operation.
  • Core operational structure of the A3BC will consist of dedicated and delineated State and National components to ensure local ownership and control, with harmonised and collaborative overall management and access.
    • The national Access Committee will provide independent review and approval for research applications to access the A3BC.
    • State Biobank Coordinators will oversee and coordinate the harmonisation of individual biobank operations management (e.g. collection to storage, database entry and maintenance, research relations) in each state, provide guidance and communication between stakeholders, and liaise with the health system (hospitals, LHDs etc) and key partners in population health and data linkage/analysis.
  • Biobank node custodianship is shared by the local Principal/Associate Investigator and Lab Manager for each state biobank facility.
  • A3BC funding is managed by the University of Sydney as they are ACNC registered (capable to take donations) and an authorised entity to manage Commonwealth grant funds.